HARROW, INC. — Director's Dealing 2008

Nov 25, 2008

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TRANSDEL PHARMACEUTICALS INC (TDLP)
CIK: 0001360214
Period of Report: 2008-11-21

Reporting Person: SWANN LYNN C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2008-11-21	Common Stock, par value $0.001 per share	A	25000	$0.70	Acquired	25000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2008-11-21	Stock Option (Right to Buy)	$0.70	A	25000	Acquired	2018-11-21	Common Stock (25000)	Direct
2008-11-21	Stock Option (Right to Buy)	$0.70	A	80000	Acquired	2018-11-21	Common Stock (80000)	Direct

Footnotes

F1: Represents shares of restricted stock subject to the following vesting schedule: one fourth (1/4) of the total shares
granted shall vest each quarter, commencing on the first full quarter following the initial grant date of November 21, 2008.

F2: The option vests and becomes exercisable in accordance with the following vesting schedule: one fourth (1/4) of the total
shares granted shall vest each quarter, commencing on the first full quarter following the initial grant date of November
21, 2008.

F3: The option vests and becomes exercisable in accordance with the following vesting schedule: one twentieth (1/20) of the
total shares granted shall vest each quarter, commencing on the first full quarter following the initial grant date of
November 21, 2008.